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A Chemical Genetic Screen for Direct v-Src Substrates
Reveals Ordered Assembly of a Retrograde
Signaling Pathway
the fundamental question of which kinase is responsible
for a given phosphorylation event remains elusive be-
cause of the presence of many kinases in the same
pathway that exhibit overlapping substrate specificities
[10] and because of the downstream effects of inhibiting
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In contrast to the poorly defined direct substrates forPharmacology
Box 0450 protein kinases, much is known about the downstream
effects of phosphoproteins [11, 12]. Two basic mecha-University of California, San Francisco
San Francisco, California 94143 nisms for conversion of a phosphorylation event into a
molecular switch have been revealed. These are regula-3 Department of Chemistry
University of California, Berkeley tion of the catalytic activity of an enzyme through a
phosphorylation-induced conformational change or theBerkeley, California 94720
induction of a protein-protein interaction via a phospho-
specific recognition domain such as an SH2 domain.
Recently, scaffolding proteins, which are an extremeSummary
example of the latter class of phosphoproteins, have
been cloned and functionally characterized in variousUsing an ATP analog that is a specific substrate for
signaling networks. These proteins typically are mem-an analog-specific allele of v-Src, we identified several
brane associated, lack enzymatic activity, and containnovel cytoskeletal substrates that control actin as-
multiple domains and phosphorylation sites. Examplessembly processes. A screen for less abundant v-Src
include Dok-1 (Downstream of kinase-1) in a variety ofsubstrates revealed the scaffolding protein Dok-1 as
tyrosine kinase cascades [13–17], Lat-1 (Linker for T cella direct substrate of v-Src. Further studies suggest
activation-1) in T cell signaling complexes [18], and Cbpthat v-Src phosphorylation sites on Dok-1 are critical
(Csk binding protein) in neurons [19]. Studies of thefor its binding to RasGAP and Csk, negative regulators
phosphorylation sites in these proteins and the subse-of Src signaling. This results in the downregulation of
quent association of SH2-containing proteins have re-growth-promoting signals of the Src family kinases
vealed the importance of scaffolding proteins in provid-and the Ras pathway. Identification of the direct sub-
ing docking sites for relocalization of cytoplasmicstrates of v-Src leads to a model for the precise order
components of the signaling apparatus to specific mem-of assembly of a retrograde signaling pathway in v-Src-
brane regions, such as lipid rafts or T cell receptor com-transformed cells and has provided new insight into
plexes. However, the presence of multiple protein ki-the balance between those signals that promote cell
nases in such complexes has made assignment of thetransformation mediated by v-Src catalyzed tyrosine
kinases that are responsible for the phosphorylation ofphosphorylation and those that inhibit it.
scaffolding proteins impossible to determine [1]. The
ability to define the precise sites on scaffolding proteins
Background phosphorylated by one kinase would allow for an under-
standing of the role of particular kinases in recruiting
Signaling networks regulated by tyrosine kinases are specific downstream effectors to these critical targets.
complex, highly interconnected, and consequently diffi- Although v-Src has been the focus of many studies
cult to dissect [1]. Tyrosine kinases are critical compo- since it was shown to possess tyrosine kinase activity,
nents of the proximal intracellular signaling machinery. its direct substrates and mechanism of cell transforma-
Yet the precise connectivity between protein kinases tion remain to be fully described [20]. Here we use a
and their downstream substrates has not been eluci- chemical method for specifically radiolabeling the direct
dated in the case of many protein kinases. This is cellular substrates of the oncoprotein v-Src. The method
because many tyrosine kinases display overlapping sub- relies on a v-Src mutant that is capable of accepting
strate specificities in vitro and can functionally compen- a non-natural phosphate donor substrate (A*TP  N6
sate for each other in single-gene knock-out experi- (benzyl) ATP) that is poorly accepted by wild-type pro-
ments [2]. Various techniques have been used to define tein kinases in the cell [21–23]. The modification of
the precise substrate phosphorylation events in signal- v-Src’s active site (I338G v-Src) so that it accepts a
ing cascades by cell lysis followed by immunoprecipita- structurally modified nucleotide analog provides a unique
tion of relevant kinase complexes [3, 4], cDNA library tool by which the direct substrates of any particular
screening [5, 6, 7], and in vitro determination of optimal kinase (v-Src) can be traced in the presence of other
peptide phosphorylation sequences [8]. Recently, mass protein kinases for the first time.
spectrometry and functional proteomics have been used A broad screen for v-Src targets in NIH 3T3 cells led
to probe the phosphorylation of substrates in intact cells to the identification of several heretofore unknown can-
by the use of a specific MKK1/2 inhibitor [9]. However, didate substrates of v-Src; these substrates are known
to be involved in cellular processes critical for cell trans-
formation. A focused screen was carried out with protein4 Correspondence: shokat@cmp.ucsf.edu
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preparations enriched for potential direct substrates of in the presence of [-32P] ATP (Figure 1B). This result is
expected because all cellular kinases utilize [-32P] ATP,v-Src. This analysis revealed a highly restricted set of
candidate direct v-Src substrates. One protein substrate and thus Figure 1B is a composite labeling of all kinase
substrates in the cell. On the other hand, Figure 1Cin particular, Dok-1, contains multiple phosphorylatable
tyrosine residues (14 sites) and is known to serve as reveals only the kinase activity of v-Src-as1 and conse-
quently required a longer exposure time to reveal pro-a scaffold protein for the recruitment of downstream
signaling components [24, 25]. Only two of the Dok-1 teins not visible in Figure 1B. Importantly, a high concen-
tration of nonradiolabeled ATP was included in allphosphorylation sites were directly phosphorylated by
v-Src. The role of phosphorylation at these sites was reactions to ensure similar overall stoichiometry of
phosphorylation and thus conservation of protein mo-analyzed in a transformation assay, and the sites were
found to be involved in the negative regulation of both bility.
Mass spectrometry was performed on eight Coomas-Ras and cytoplasmic tyrosine kinases in the Src family.
This analysis has allowed us to generate a model linking sie-stained protein spots that corresponded to radioac-
tively labeled spots in Figure 1C. Five proteins werea specific sequence of v-Src phosphorylation events to
two different retrograde signaling mechanisms in two identified from a database search and are listed in Table
1. Three substrates, tubulin -2, tubulin -5, and  eno-distinct Dok-1 complexes. Since the presence of multi-
ple protein kinases in signaling complexes has made lase, have been previously identified as substrates of
v-Src based on studies in several cell types [26–28]. Ourassignment of the kinases responsible for site-specific
phosphorylation of scaffolding proteins all but impossi- direct labeling data support these earlier studies. The
remaining two proteins, Cofilin and Calumenin, are novelble to determine, this model represents the first view of
multiprotein complexes at this resolution. candidate substrates of v-Src.
One caveat of our whole-cell screen for direct v-Src
substrates is the possibility that substrate phosphoryla-
Results and Discussion tions in the cell lysate may not accurately recapitulate
phosphorylation events in the intact cell. Two facts ar-
Global Analysis of Direct v-Src Targets Reveals gue against this being a substantial issue with our study.
New Substrates Firstly, our method is able to efficiently radiolabel direct
v-Src-induced transformation of fibroblasts leads to the substrates without the need to overexpress the kinase
tyrosine phosphorylation of more than 50 proteins [20]. v-Src at a level that was not achieved in the intact cell.
However, it is not clear if all of these proteins are direct Such a level might cause aberrant or incorrect sub-
v-Src substrates or if they are phosphorylated as a con- strates to become labeled. Secondly, our screen re-
sequence of the v-Src activation of other kinases. We vealed three proteins previously identified by other
carried out a global analysis of direct v-Src substrates methods as v-Src substrates.
by using v-Src-as1(v-Src-analog-sensitive-1) NIH 3T3 Cofilin and Calumenin, the remaining proteins identi-
cells and [-32P] N6 (benzyl) ATP. The use of [-32P] N6 fied by mass spectrometry, are novel candidate sub-
(benzyl) ATP allows the exclusive labeling of v-Src-as1 strates, not previously suggested to be substrates of
substrates because the ATP analog is not a substrate v-Src. Cofilin is a 21 kDa actin-depolymerizing protein
for wild-type protein kinases [21]. Furthermore, [-32P] and is essential for cytokinesis, endocytosis, T cell stim-
N6 (benzyl) ATP is an efficient substrate for v-Src-as1 ulation, and other cellular processes that require rapid
[22]. Whole-cell kinase assays with both v-Src and actin dynamics [29]. Regulation of Cofilin depends on
v-Src-as1 NIH 3T3 cell lysates with [-32P] ATP showed several factors, including phosphorylation and dephos-
an indistinguishable pattern of phosphoproteins (Figure phorylation [30]. To date, S3 is the only Cofilin phosphor-
1A, lane 1 versus lane 3) and confirmed similar substrate ylation site that has been shown to be critical for actin
specificities of both the wild-type and mutant v-Src. The binding [30]. According to our mass spectrometry data,
similarity in total cellular phosphoprotein content agrees Y117 is likely to be the direct v-Src phosphorylation site
well with previous data showing that as1 mutant kinases on Cofilin.
exhibit the same phosphoacceptor specificity and regu- Since Cofilin has not been previously shown to be
latory properties of the corresponding wild-type kinases tyrosine phosphorylated and is not known to be a direct
[21, 22] (Witucki et al., this issue of Chemistry & Biology, substrate of v-Src, we wondered if our mass spectrome-
pp. 25–33). Labeling of v-Src-as1 NIH 3T3 cell lysates try analysis could have misidentified Cofilin because of
with [-32P] N6 (benzyl) ATP showed a different phosphory- misalignment of the two-dimensional Coomassie-
lation pattern, as expected, since only the direct sub- stained gel with the autorad. To ask if v-Src is likely to
strates of v-Src-as1 are radiolabeled (Figure 1A, lane 4). be the kinase responsible for the phosphorylation of
As a control, identical kinase assays with v-Src NIH 3T3 Cofilin, we immunoblotted the v-Src NIH 3T3 cell ly-
cell lysates containing [-32P] N6 (benzyl) ATP were also sate with the anti-phosphotyrosine-specific antibody
performed. Minimal labeling occurred in this case (Fig- 4G10 (Figure 1D, lane 1). No band was observed at
ure 1A, lane 2). the expected MW of Cofilin (21 kDa). To enrich for the
To further resolve the direct v-Src substrates from presence of cellular Cofilin, we used the anti-Cofilin anti-
other phosphorylated proteins, we carried out 2D gel body (sc8442) to immunoprecepitate Cofilin from the
electrophoresis on v-Src-as1 NIH 3T3 cell lysates phos- same cells, which revealed intense phosphotyrosine
phorylated with either [-32P] ATP or [-32P] N6 (benzyl) staining of Cofilin. We next isolated v-Src immune com-
ATP. More than 20 proteins were phosphorylated with plexes and found the same intense phosphotyrosine-
containing 21 kDa protein, suggesting that Cofilin is both[-32P] N6 (benzyl) ATP (Figure 1C) but were not detected
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Figure 1. Differential Phosphorylation of Di-
rect v-Src Substrates in v-Src-as1 NIH 3T3
Cell Lysate with [-32P]N6(Benzyl)ATP
(A) Kinase reactions of v-Src and v-Src-as1
NIH 3T3 cell lysate in the presence of 100 M
ATP and either [-32P] ATP (lanes 1 and 3) or
[-32P]N6(benzyl)ATP (lanes 2 and 4) for 45 min
at room temperature. Reaction products were
separated on 10% SDS-PAGE, transferred to
PVDF membrane, and analyzed by autoradi-
ography.
(B) 2D gel electrophoresis of the kinase reac-
tion of v-Src-as1 NIH 3T3 cell lysate and
[-32P] ATP in the presence of 100 M ATP for
45 min. The internal standard (tropomyosin) is
shown as an arrow at molecular weight 33 K
and pI 5.2. The top image is Autorad. In the
bottom image, the gels were stained with
Coomassie blue, dried, and scanned.
(C) 2D gel electrophoresis of the kinase reac-
tion of v-Src-as1 NIH 3T3 cell lysate and
[-32P] A*TP in the presence of 100 M ATP
for 45 min. The top image is Autorad. In the
bottom image, the gels were stained with
Coomassie blue, dried, and scanned.
(D) The lysates from wild-type v-Src were
subjected to immunoprecipitation either with
anti-Cofilin antibody (lane 2) or anti-Src (mAb
327) antibody (lane 3). Lane 1 represents
whole-cell lysate. Proteins were separated on
10% SDS-PAGE, transferred to PVDF mem-
brane, and immunoblotted with anti-p-Tyr
(4G10).
(E) Kinase reactions of v-Src and v-Src-as1
immunoprecipitates either in the absence
(lanes 1 and 4) or in the presence of Cofilin
(lanes 2, 3, 5, and 6). Reactions were initiated
either with [-32P] ATP (lanes 1, 2, 4, and 5)
or [-32P] N6(benzyl)ATP (lanes 3 and 6) for 20
min at room temperature. Reaction products
were separated on 10% SDS-PAGE, trans-




alternative to whole-cell lysate screening for direct v-SrcTable 1. Direct v-Src Substrates Identified by 2D Gel
Electrophoresis and Mass Spectral Analysis substrates. We predicted that the use of v-Src immuno-
precipitations to enrich for v-Src substrates prior to 32PSubstrates Accession Number
labeling would allow the identification of substrates
Calumenin O35887 present at low concentration and those substrates that
Cofilin P18760
are phosphorylated at low stoichiometry. This techniqueTubulin alpha-2 chain P05213
has been used by many investigators to enrich for kinaseTubulin beta-5 NP_035785
substrates [35, 36]. v-Src-as1-containing complexesAlpha enolase P17182
were immunoprecipitated by GD11 from v-Src-as1 NIH
In brief, gel spots were digested with trypsin, followed by MALDI
3T3 cells, and [-32P] N6 (benzyl) ATP was added to themass spectrometric analysis with a PerSeptive Voyager DE-RP mass
immune complex. As controls, we carried out identicalspectrometer in the linear mode. These peptides were analyzed by
peptide mass fingerprinting and data base searching with Protein kinase assays with immune complexes isolated from
Prospector. v-Src NIH 3T3 cells and incubated with [-32P] N6 (benzyl)
ATP (negative control) or [-32P] ATP (positive control).
When v-Src-as1 was immunoprecipitated from pooled
present and tyrosine phosphorylated in complex with
v-Src-as1 NIH 3T3 and incubated with [-32P] N6 (benzyl)v-Src, consistent with it being a substrate of v-Src. The
ATP, the three most prominently phosphorylated pro-fact that Cofilin was not visible in a whole-cell phospho-
teins observed were v-Src, p62, and p120 (Figure 2A,tyrosine immunoblot is consistent with it being present
lane 4). The proteins were identified based on previousat low concentration or at low phosphorylation stoichi-
studies of v-Src-associated proteins as well as by useometry, a situation not uncommon for critical kinase
of antibodies to the candidate proteins [20]. The p62substrates [24–25].
protein was identified as the scaffolding protein Dok-1,To confirm that v-Src is capable of direct phosphoryla-
a component of the RasGAP complex in transformedtion of Cofilin, we asked if purified Cofilin is phosphory-
fibroblasts [24, 25]. Further confirmation of the identitylated by v-Src in an in vitro kinase reaction. When Cofilin
was carried out by phospho-tryptic mapping of the ra-was added to a v-Src immune complex kinase assay
diolabeled protein (see below). The p120 protein waswith [-32P] ATP, a new 21 kDa band is intensely labeled
identified as focal adhesion kinase (Fak), a kinase acti-(Figure 1D, lane 2). Furthermore, this same band is la-
vated in response to both integrin-ECM (extracellularbeled when the v-Src-as1 immune complex is provided
matrix) interactions [37] and the engagement of certainwith [-32P] N6 (benzyl) ATP, confirming that Cofilin phos-
tyrosine kinase growth factor receptors [38] as well asphorylation is a direct consequence of v-Src-as1 activ-
certain G protein-coupled receptors [39]. Fak also func-ity. Together, the studies of the intracellular tyrosine
tions as a scaffolding protein that binds several signalingphosphorylation state of Cofilin (Figure 1D) and the abil-
cytoskeletal molecules, after its full activation by Srcity of v-Src to phosphorylate purified Cofilin in vitro
(reviewed in [40–42]).strongly support the identification of Cofilin as a direct
Because we identified Fak as a direct v-Src substrate,cellular substrate of v-Src. Cytoskeletal reorganization
and because it is known to bind to certain cytoskeletalis the hallmark of v-Src transformed fibroblasts; direct
elements, we used Fak-specific antibodies and antibod-phosphorylation of Cofilin by v-Src may reveal a new
ies against cortactin, another putative Src substrate thatmechanism for this regulation.
regulates cytoskeletal reorganization in vivo [43], to en-The other novel candidate direct v-Src substrate, Cal-
rich for other potential v-Src substrates in the cytoskele-umenin, is localized to the ER. Other ER resident pro-
tal compartment. Fak and cortactin immune complexesteins, such as BiP, have been suggested to be Src kinase
were isolated from both v-Src and v-Src-as1 NIH 3T3substrates [31], which would suggest that this cellular
cells. Kinase assays with the v-Src-as1 NIH 3T3 lysatescompartment may contain other v-Src substrates as
in the presence of [-32P] N6 (benzyl) ATP revealed thatwell. Calumenin belongs to a newly identified family of
both Fak and cortactin were phosphorylated (Figuresmultiple EF-hand proteins called the CREC (Cab45, Reti-
2B and 2C), verifying that they are indeed direct Srcculocalbin, ERC-45, Calumenin) family [32]. The exact
targets. The only other protein identified in these com-function of CREC family proteins are not known, but
plexes as a direct v-Src-as1 substrate was Dok-1. Therecent evidence shows that Reticulocalbin is overex-
fact that Dok-1 is present in multiple immune complexespressed in highly invasive breast cancer cell lines [33],
(anti-v-Src, anti-Fak, anti-cortactin), and that it is a directand ERC-55 is implicated in cervicical cancer [34]. To
substrate of v-Src in each case, led us to focus ondate, there have been no reports of tyrosine phosphory-
the role of Dok-1 phosphorylation as a potential centrallation of any of the CREC family members. In view of
regulator of cellular transformation. Furthermore, sincethe fact that some of the CREC family members are
Dok-1 is present in low abundance, we suspected itoverexpressed in breast and cervical cancer, phosphor-
might be a limiting mediator of v-Src signaling [24, 44].ylation of Calumenin by v-Src may have important con-
sequences related to metastasis. We are currently elic-
iting antibodies against a C-terminal peptide sequence
Dok-1 Is Not a Direct v-Src Substrate Whenin Calumenin to facilitate studies to assess the intracellu-
Dok-1 Is in the RasGAP Complexlar tyrosine phosphorylation status of this protein.
Dok-1 was initially cloned as a RasGAP-associated pro-
tein. Previous data [45] have shown that the RasGAPv-Src Has a Restricted Repertoire
immune complex contains a tyrosine kinase(s) that isof Direct Targets
capable of phosphorylating Dok-1 and other proteins.Association of the novel v-Src substrate Cofilin in a
protein complex with v-Src (Figure 1D) suggested an However, this kinase is present in very low abundance
Chemical Genetic Screen for Direct v-Src Substrates
39
Figure 2. Different Immune Complexes Iso-
lated from v-Src and v-Src-as1 NIH 3T3 Cells
Were Reacted with ATP or [-32P]N6(Ben-
zyl)ATP
(A) Anti-v-Src immune complex kinase reac-
tion in v-Src and v-Src-as1 NIH 3T3 cells. In
the top image, the lysates from wild-type
v-Src (lanes 1 and 2) and v-Src-as1 NIH 3T3
cells (lanes 3 and 4) were subjected to immu-
noprecipitation with anti-Src (GD11) anti-
body. The immune complexes were incu-
bated in the presence of [-32P] ATP (lanes 1
and 3) or [-32P]N6(benzyl)ATP (lanes 2 and
4) for 10 min at room temperature. Reaction
products were separated on 10% SDS-PAGE,
transferred to PVDF membrane, and analyzed
by autoradiography. In the bottom image, the
same PVDF membrane was analyzed by West-
ern blotting with anti-Src antibody (EC10) as
a loading control.
(B) Anti-Fak (2A7) immune complex kinase
reaction in v-Src and v-Src-as1 NIH 3T3 cells.
In the top panel, the lysates from v-Src (lanes
1 and 2) and v-Src-as1 NIH 3T3 cells (lanes
3 and 4) were subjected to immunoprecipita-
tion with anti-Fak antibody. The immune com-
plexes were incubated in the presence of
[-32P] ATP (lanes 1 and 3) or [-32P]N6(benzy-
l)ATP (lanes 2 and 4) for 15 min at room tem-
perature. Reaction products were separated
on 10% SDS-PAGE, transferred to PVDF
membrane, and analyzed by autoradiogra-
phy. In the bottom image, the same PVDF
membrane was probed with anti-Fak anti-
body as a loading control.
(C) Anti-cortactin immune complex kinase re-
action in v-Src and v-Src-as1 NIH 3T3 cells.
In the top image, the lysates from v-Src (lanes
1 and 2) and v-Src-as1 NIH 3T3 cells (lanes
3 and 4) were subjected to immunoprecipita-
tion with anti-cortactin (4F11) antibody. The
immune complexes were incubated in the
presence of [-32P] ATP (lanes 1 and 3) or
[-32P]N6(benzyl)ATP (lanes 2 and 4) for 15 min
at room temperature. Reaction products
were separated on 10% SDS-PAGE, trans-
ferred to PVDF membrane, and analyzed by
autoradiography. In the bottom images, the
PVDF membrane was analyzed by immu-
noblotting with the anti-cortactin antibody
(4F11) and an anti-Dok anti-sera (M-276) as
loading controls.
(D) Anti-RasGAP immune complex kinase re-
action in v-Src and v-Src-as1 NIH 3T3 cells.
In the top image, the lysates from v-Src (lane
1) and v-Src-as1 NIH 3T3 cells (lanes 2 and
3) were subjected to immunoprecipitation with anti-RasGAP (B4F8) antibody. The immune complexes were incubated in the presence of
[-32P] ATP (lanes 1 and 2) or [-32P]N6(benzyl)ATP (lanes 3) for 10 min at room temperature. Reaction products were separated on 10% SDS-
PAGE, transferred to PVDF membrane, and analyzed by autoradiography. In the bottom image, the PVDF membrane was subjected to
immunoblotting with the anti-Dok anti-sera (M-276) as a loading control.
and, therefore, could not be identified by immunoblot- is phosphorylated in a v-Src-as1-dependent manner.
This p66 band is not a hyperphosphorylated form ofting [46]. Since this RasGAP-associated kinase activity
was only found in v-Src-transformed cells, v-Src was Dok-1, as determined by immunoblotting with poly-
clonal sera capable of detecting phosphorylated Dok-1thought to be the responsible kinase. To determine if
v-Src was directly responsible for the phosphorylation of [47] (data not shown). This result indicates that v-Src
is present in the RasGAP complex and confirms theDok-1 in the RasGAP complex, we immunoprecipitated
RasGAP from v-Src-as1 NIH 3T3 cells. Strikingly, Dok-1 suggestion by McCormick and coworkers [45]. Thus,
Dok-1 is phosphorylated not by v-Src, but by an as-yet-is not phosphorylated when v-Src-as1 is provided with
the orthogonal substrate [-32P] N6 (benzyl) ATP (Figure undefined kinase in the complex. Unfortunately, neither
the other kinase responsible for the phosphorylation of2D, lane 3). Instead, an unidentified 66 kDa protein (p66)
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Dok-1 nor the identity of p66 could be identified (data were replaced by nonphosphorylatable phenylalanine
residues (Figure 4). The Y1 peptide corresponds to anot shown). It is likely that v-Src phosphorylates Dok-1
prior to its binding to RasGAP and thus fails to further tryptic peptide containing one phosphorylatable tyro-
sine (Y295). Due to weak phosphorylation of Y295 inphosphorylate Dok-1 in a RasGAP complex. Another
possibility is that RasGAP binding to Dok-1 somehow v-Src and v-Src-as1 immune complexes with [-32P] ATP
(Figure 3, maps a and b), it cannot be ruled out thatdislodges v-Src, so that relevant Dok-1 phosphorylation
sites are no longer accessible to v-Src. It is intriguing v-Src phosphorylates this site directly but at very low
efficiency.that although v-Src is present and active in multiple
complexes (anti-Fak, anti-cortactin, and anti-RasGAP), v-Src-as1 directly phosphorylates sites correspond-
ing to peptides Y2 (Dok-1, Y361) and Y3 (Dok-1, Y450)it is not a promiscuous kinase that always phosphory-
lates a given protein (Dok-1) in all signaling complexes. (Figure 3, map c, lower right). Surprisingly, one Dok-1
phosphorylation site (peptide Y4) does not contain aOther kinases in these complexes are responsible for
highly specific phosphorylation events, revealing such v-Src phosphorylation site. We were unable to identify
the Dok-1 site corresponding to the Y4 peptide, althoughprotein complexes to be more dynamic and specifically
regulated by individual kinases than previously ap- it was confirmed by phosphoamino acid analysis that it
contained a phosphotyrosine residue (data not shown).preciated.
One of the v-Src-as1 phosphorylation sites (Y2 
IY361DEP) agrees quite well with the known in vitro speci-Dok-1 Is a Key Kinase Target and Scaffold
ficity of Src as determined by peptide library screeningfor Adaptor Proteins
[52, 53]. However, the other site (Y3  LY450QSV) wasThe finding that Dok-1 is frequently a direct substrate
not predicted to be an optimal consensus phosphoryla-of v-Src in multiple signaling complexes (v-Src, Fak,
tion site for Src (see below) [52]. The identification ofand cortactin) and yet is not phosphorylated in other
Y450 as a direct phosphorylation site for v-Src highlightscomplexes (RasGAP) led us to investigate the role of
the ability of protein tyrosine kinases to phosphorylatev-Src in the production of highly phosphorylated forms
sites that are not predictable purely based on their opti-of Dok-1. The difficulty in answering this question is that
mal peptide specificity.almost every tyrosine kinase tested has been reported
to phosphorylate Dok-1. It is the major tyrosine phos-
phorylated protein in cells transformed by oncogenic v-Src Specifically Phosphorylates Dok-1
tyrosine kinases such as v-Abl, v-Src, v-Fps, and v-Fms at RasGAP and Csk Docking Sites
[13]. Furthermore, Dok-1 has been shown to become Tyrosine-phosphorylated Dok-1 acts as a scaffold for
tyrosine phosphorylated after platelet-derived growth proteins containing SH2 or PTB domains (17, 48, 49).
factor (PDGF) [14, 15], epidermal growth factor (EGF) In order to identify these proteins, HA-tagged Dok-1
[16], and insulin stimulation [17], providing a link be- phosphorylation site mutants (Y295F, Y361F, and
tween growth factor receptors and MAP kinase activa- Y450F) were immunoprecipated from v-Src NIH 3T3 cells
tion. Upon phosphorylation, Dok-1 has been shown to and probed with antibodies for known Dok-1-associated
interact with multiple signaling proteins, including Grb2 proteins (v-Src, RasGAP, and Csk). The pY361 site on
[48], Nck [49, 50], RasGAP [24, 25], and PLC [48]. Inter- Dok-1 has been shown to bind Nck upon insulin stimula-
estingly, Dok-1 has emerged as a key negative regulator tion [50]. The Y314F Dok-1 mutant was included as a
of several receptor and cytoplasmic tyrosine kinase cas- negative control because it contains the identical YXXP
cades. In particular, the pleckstrin homology (PH) do- motif found at Y295 and Y361 yet was not found to be
main and the phosphotyrosine binding (PTB) domain as phosphorylated by v-Src. All Dok-1 mutants had similar
well as the oligomerization domain of Dok-1 have been expression levels, as confirmed by immunoblotting with
recently shown to be required for this negative regula- a Dok-1-specific antibody (data not shown).
tory activity [44]. We sought to study the role of the We found that the v-Src binding site on Dok-1 is Y361.
tyrosine kinase v-Src in formation of specific phospho- Anti-v-Src immune complexes were isolated, and the
forms of Dok-1 and to determine if these phosphoryla- binding of the HA-Dok-1 mutants was determined by
tion events were important in the regulation of cellular immunoblotting with an anti-HA antibody. Dok-1 mu-
function. tants Y295F, Y314F, and Y450F bound efficiently to
v-Src, whereas Y361F Dok-1 binding to v-Src was se-
verely decreased (Figure 5A, lane 4). This suggests thatv-Src Phosphorylates Only a Subset of the Dok-1
Phosphorylation Sites Y361 is the site most responsible for Dok-1’s binding
to v-Src. The weak v-Src binding observed to the Y361FSince Dok-1 contains multiple phosphorylation sites,
we sought to map the specific sites that are directly Dok-1 mutant (Figure 5A, lane 4) is probably mediated
by v-Src’s SH3 domain [54].phosphorylated by v-Src via two-dimensional phospho-
peptide mapping of v-Src-as1’s direct phosphorylation Dok-1 contains a YXXP motif at Y295, Y314, and Y361,
suggesting that all three sites could provide a site forsites on Dok-1 [51]. Four phosphotyrosine-containing
peptides from a tryptic digest of Dok-1 are radiolabeled RasGAP binding [52, 53]. Probing the HA-Dok-1 immune
complexes for RasGAP binding revealed that all four(Y1-Y4) with [-32P] ATP and either v-Src (Figure 3, map
a) or v-Src-as1 (Figure 3, map b). The identities of the mutants are capable of binding to RasGAP, although
Dok-1(Y295F) and Dok-1(Y361F) bind much less effi-tryptic peptides derived from Dok-1 were determined
by a combination of mobility prediction [51] and an anal- ciently, suggesting that both of these sites may be in-
volved in binding to RasGAP (Figure 5B). When theseysis of Dok-1 mutants in which specific tyrosine residues
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Figure 3. Phosphotryptic Maps of Dok-1
Phosphotryptic digests of Dok-1 protein iso-
lated from v-Src immunoprecipitates from
v-Src and v-Src-as1 NIH 3T3 cells after kinase
reactions with either [-32P] ATP (lanes 1 and
3) or [-32P]N6(benzyl)ATP (lanes 2 and 4).
two sites were mutated simultaneously (Y295/361F), Phosphorylation of Dok-1 Y361 Reduces
Src-Dependent Transformationfaint binding to RasGAP was still observed, implying that
additional sites on Dok-1 may be involved in RasGAP Phosphorylation of Dok-1 at Y361 results in the binding
of RasGAP to Dok-1 and subsequent inhibition of cellu-binding. Since the Y361 site on Dok-1 is directly phos-
phorylated by v-Src, v-Src may be responsible in part lar transformation. The functional relevance of v-Src
phosphorylation of Dok-1 in terms of cellular transforma-for the recruitment of RasGAP to the Dok-1 scaffold.
This provides the first direct link between a specific tion was probed with a genetic screen to measure the
transforming potential of individual phosphorylation sitephosphorylation event on Dok-1 and recruitment of a
component of the Ras signaling machinery. mutants of Dok-1. An initial screen of Dok-1 mutants with
v-Src-transformed NIH 3T3 cells revealed no positiveOur analysis of the Y450 phosphorylation site on
Dok-1 suggests that Csk binds to this site. The Y450 or negative effects of Dok-1 phosphorylation (data not
shown). We then used a mutant [c-Src (T338I, Y527F)]site on Dok-1 contains a Val at the Y 3 position (YSQV)
and the pYXXV motif has been shown to be an optimal that causes partial (5%–10%) transformation relative to
v-Src isolates [56], which allowed the assessment ofbinding site for the Csk SH2 domain [55]. Neet and
Hunter [3] proposed that the adaptor protein Dok-1 me- both positive and negative effects of Dok-1 mutants on
Src-dependent cellular transformation. Four single phos-diates the localization of Csk to subcellular membrane
and cytoskeletal regions in v-Src- and activated c-Src- phorylation site mutants of HA-dok-1 (Y295F, Y314F,
Y361F, and Y450F) as well as wild-type dok-1 were in-transformed cells. Probing anti-Csk immune complexes
with an HA-specific antibody revealed that the binding troduced into c-Src (T338I, Y527F) cells by retroviral
infection. Immunoblotting with a Dok-1-specific anti-of Dok-1 to Csk is completely abolished by the mutation
of Y450 (Figure 5C), suggesting that Y450 is the major body confirmed that all Dok-1 mutants had similar ex-
pression levels (data not shown). Soft agar growthsite of interaction between Csk and Dok-1. These results
suggest that the mechanism responsible for Csk’s re- assays were performed with each of the dok-1-express-
ing c-Src (338I, 527F)-transformed cell lines (each as acruitment from the cytosol to the membrane is the v-Src-
dependent phosphorylation of Dok-1 at Y450. pooled population). Expression of wild-type Dok-1 has
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Figure 4. Phosphotryptic Maps of Different Y-to-F Mutants of Dok-1
Different GST-Dok-1 mutant proteins were expressed in E. coli and were phosphorylated with v-Src immunoprecipitates from v-Src NIH 3T3
cells with [-32P] ATP. Proteins were resolved on 10% SDS-PAGE and electrophoretically transferred to nitrocellulose membrane. 32P-labeled
GST-Dok-1 bands were excised from the nitrocellulose membrane, and phosphotryptic peptide mapping procedures were carried out as
described in the Experimental Procedures.
an inhibitory effect on transformation (85% inhibition), transformation is controlled by direct phosphorylation
of a single site on Dok-1, which recruits RasGAP toconfirming that Dok-1 is involved in the negative regula-
tion of Src-dependent transformation [44]. When either the Dok-1 scaffold. Recent studies by Baltimore and
coworkers have shown that the PH domain as well asY295F or Y361F HA-dok-1 was expressed, 80%–85%
of this inhibition was lost in comparison to wild-type a multimerization domain present in Dok-1 are also nec-
essary for negative regulation of Src-dependent trans-dok-1-expressing c-Src (338I, 527F) cells (Figure 6). Be-
cause Y295 and Y361 are RasGAP binding sites on formation [44]. Together, these results suggest that
Dok-1 requires multiple inputs, including phosphoryla-Dok-1, this suggests that phosphorylation of these sites
plays a role in inhibition of the Ras pathway. Expression tion, membrane localization, and multimerization, in or-
der to serve as a negative regulator of tyrosine kinase-of the dok-1(Y450F) allele, which is defective in binding
Csk, showed little effect on cellular transformation. The dependent cell transformation.
role of Csk is to phosphorylate Y527 of Src family kinases
[57], and so it is expected that Csk recruitment had no Significance
effect on transformation by a c-Src allele lacking the
C-terminal tyrosine 527. Our analysis reveals that 80%– Global analysis of direct v-Src substrates in v-Src-
transformed fibroblasts led to the identification of sev-85% of the negative regulatory function of Dok-1 on cell
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Figure 5. Identification of Downstream Proteins Recruited on Dok-1 as a Result of v-Src-Mediated Phosphorylation
(A) Anti-v-Src immunoprecipitation from v-Src NIH 3T3 cells coexpressing either dok-1, dok-1(Y295F), dok-1(Y314F), dok-1(Y361F), or dok-
1(Y450F). In the top image, the lysates from dok-1, dok-1(Y295F), dok-1(Y314F), dok-1(Y361F), or dok-1(Y450F)-expressing cells (lanes 1–5)
were subjected to immunoprecipitation with anti-Src antibody (GD11). Reaction products were separated on 10% SDS-PAGE, transferred to
PVDF membrane, and analyzed by immunoblotting with an anti-HA antibody. In the bottom image, the PVDF membrane was subjected to
immunoblotting with an anti-Src antibody (EC10) as a loading control.
(B) Anti-HA immunoprecipitation from v-Src NIH 3T3 cells coexpressing either dok-1, dok-1(Y295F), dok-1(Y314F), dok-1(Y361F), dok-1(Y450F),
or dok-1(Y295F/Y361F). In the top image, the lysates from dok-1, dok-1(Y295F), dok-1(Y314F), dok-1(Y361F), dok-1(Y450F), or dok-1(Y295F/
Y361F) (lanes 1–5) expressing v-Src NIH 3T3 cells were subjected to immunoprecipitation with anti-HA antibody. Reaction products were
separated on 10% SDS-PAGE, transferred to PVDF membrane, and analyzed by immunoblotting with the anti-RasGAP antibody B4F8. In the
bottom image, the PVDF membrane was subjected to immunoblotting with anti-HA antibody as a loading control.
(C) Anti-Csk immunoprecipitation from v-Src NIH 3T3 cells coexpressing either dok-1, dok-1(Y295F), dok-1(Y314F), dok-1(Y361F), or dok-
1(Y450F). In the top image, the lysates from v-Src NIH 3T3 cells coexpressing either dok-1, dok-1(Y295F), dok-1(Y314F), dok-1(Y361F), or
dok-1(Y450F) were subjected to immunoprecipitation with the anti-Csk antibody (C-20). Reaction products were separated on 10% SDS-
PAGE, transferred to PVDF membrane, and analyzed by immunoblotting with an anti-HA antibody. In the bottom image, the PVDF membrane
was subjected to immunoblotting with anti-Csk antibody as a loading control.
eral novel direct v-Src targets, including Cofilin and v-Src phosphorylation site was one of the directly
phosphorylated sequences. One of the v-Src phos-Calumenin. A more focused screen for v-Src sub-
strates revealed a model for the assembly of negative phorylation sites (Y361) on Dok-1 produces an optimal
binding site for v-Src. This association may allow v-Srcregulatory proteins onto the scaffolding protein Dok-1.
These studies revealed a number of surprising fea- to phosphorylate the suboptimal phosphorylation site.
Such a processive phosphorylation model has beentures of v-Src substrates that contradict currently ac-
cepted models of tyrosine kinase specificity. In one proposed by Cantley [52] and by Scott and Miller [58].
The role of Dok-1 phosphorylation by v-Src is to recruitexample, we found that out of four phosphorylation
sites on Dok-1, only two were definitively sites phos- negative regulators of cellular transformation. Muta-
tion of v-Src phosphorylation sites Y295 or Y361 abro-phorylated by v-Src, even though three of the four
sites shared a similar consensus sequence. Moreover, gated the inhibitory effect of Dok-1 on cellular trans-
formation, indicating that these sites are necessarythe site that was predicted to provide a nonoptimal
Figure 6. Functional Relevance of Dok-1
Phosphorylation in Cellular Transformation
Soft-agar colony formation assays were per-
formed with either c-Src(T338I/Y527F) NIH
3T3 cells alone or c-Src(T338I/Y527F) NIH
3T3 cells coexpressing dok-1, dok-1(Y295F),
dok-1(Y314F), dok-1(Y361F), or dok-1(Y450F).
Relative transformation efficiencies show the
mean of three independent experiments, and




N6(benzyl) ADP (2.5 mol, molar absorbancy (max) 15.4  103 at
265 nm at pH 7.00) was dissolved in DMF (200 l), and carbonyl
diimidazole (8 mg, 10 mol) was added to it. The reaction mixture
was stirred for 24 hr at room temperature, then methanol (4 l)
was added and the reaction was stirred for an additional 1 hr. 32P
orthophosphoric acid (5 mCi, 8500 Ci/mmol) was dried in vacuo,
dissolved in DMF (100 L), and added to the reaction mixture. After
the mixture was stirred for 24 hr, DMF was removed in vacuo, and the
radiolabeled analog was purified by ion-exchange chromatography
with DEAE (1.5 cm  7 cm packed volume) and a gradient of 0.1–1
M TEAB buffer (pH 7.5) at a flow rate of 1.5 ml/min. The purified
product was concentrated in vacuo at	40
C by rotary evaporation.
The concentrated triphosphate was redissolved in 200 l water, and
the concentration was determined by scintillation counting (yield
20%). The [-32P] N6(benzyl) ATP was characterized by coinjectionFigure 7. v-Src-Mediated Phosphorylation of Dok-1 Negatively
of the radiolabeled material with an authentic sample of N6(benzyl)Regulates Both Ras and Growth Factor-Stimulated Pathways
ATP [8] on a strong anion exchange-HPLC column (retention timeProposed model for a retrograde signaling pathway for c-Src(Y527F,
11.2 min).T338I) or v-Src. The pathway is mediated by the adaptor protein
Dok-1 and its effect in cellular transformation. Red circles represent
Antibodiessites directly phosphorylated by v-Src. Red ovals represent kinase
Anti-v-Src antibodies GD11 and EC10 (1 g/l) were a generousdomains; yellow and green ovals represent SH2 and SH3 domains,
gift from Sally Parsons (University of Virginia, Charlottesville). Tomrespectively.
Parsons (University of Virginia, Charlottesville) provided Fak anti-
body 2A7 and cortactin antibody 4F11. Anti-RasGAP antibody B4F8,
anti-Csk (C-20), anti-Cofilin (sc8442), and anti-Dok antibody M-276
for the repression of transformation activity. The pro- were purchased from Santa Cruz Biotech. Anti-HA (12CA5) was
tein that associates with Dok-1 at pY295 and pY361 from Roche Biochemicals; mAb 327 was purchased from Oncogene
Research Products. Goat antimouse HRP was purchased from ICNis RasGAP, a negative regulator of the Ras signaling
(catalog number 55550), and goat antirabbit HRP was purchasedpathway that is critical for cellular transformation by
from VWR (catalog number RL611-103-122). FITC-conjugated goatv-Src [59]. Thus, recruitment of RasGAP as a result of
anti-rabbit and Texas Red-conjugated goat anti-mouse antibodiesv-Src-mediated phosphorylation on Dok-1 highlights
were purchased from Jackson Immunoresearch.
another arm of retrograde signaling that is controlled
by v-Src itself (Figure 7). The chemical genetic ap- Expression Plasmids
proach used here to specifically tag the direct sub- Babe puro vector and Babe hygro vector were gifts from Alex Muller
and H. Land. Murine HA-tagged dok-1 cDNA was a gift from Yujistrates of one kinase in the cell has revealed an un-
Yamanashi (University of Tokyo, Japan). Wild-type v-Src was clonedexpected level of substrate specificity. Since the
into the pBabe puro vector [61] at BamHI and HindIII sites as follows.mutation that renders v-Src able to utilize [-32P] N6
Wild-type v-Src DNA was amplified by PCR with primers 5-GCTA(benzyl) ATP can be identified in all protein kinases
CAGTGGATCCATGGGGAGTAGCAAGAGCAAGC-3 (primer 1) and
by simple sequence alignment, this method can be 5-GCTACAGTAAGCTTCTACTCAGCGACCTCCAACACAC-3
used to decipher complex cascades one kinase at a (primer 2), Pfu polymerase (Stratagene), and 100 ng of template; 30
amplification cycles (94
C for 45 s, 55
C for 45 s, and 72
C for 3time [21].
min) were used. The I338G v-Src mutant (v-Src-as1) was produced
by the overlap extension PCR mutagenesis method with primers 1,Experimental Procedures
2, 3, and 4. Primers 3 (5-CTACATCGTCGGCGAGTACATGAG-3)
and 4 (5-CTCATGTACTCGCCGACGATGTAG-3) contain the nucle-Synthesis of [-32P] N6(Benzyl) ATP ([-32P] A*TP)
N6(benzyl)adenosine was synthesized by refluxing 6-chloropurine otide sequence changes that introduce the I338G mutation (shown
in bold). Wild-type v-Src pBabe Hygro was constructed by cloningriboside (1 mmol) (Aldrich) with benzylamine (5 mmol) in ethanol (10
ml) overnight. Ethanol was removed in vacuo, and the resulting oily at EcoRI and SalI sites with the following primers: 5-GCTACAGT
GAATTCATGGACGGGGGCTGT-3 (primer 5) and 5-GCTACAGTGresidue that was obtained was crystallized from ethanol (yield 90%).
N6 (benzyl) ADP was synthesized by sequential phosphorylation TCGACTCAGGTGGAACCCTCAGA-3 (primer 6). HA-tagged GST-
dok-1 was constructed by PCR with murine dok-1 cDNA as a tem-according the method of Hecht and Kozarich [60]. To an ice-cooled
suspension of N6(benzyl) adenosine (68 mg, 0.2 mmol) in trimethyl plate [22] and the following phosphorylated primers: 5-GGC
CATGGCTTACCCATACGATGTTCCAGATTACGCTGACGGGGCTGphosphate (0.5 mmol), POCl3 (0.025 ml) was added, and the reaction
mixture was stirred at 0
C for 1 hr, after which the reaction was TGATGGAGGGTCCG-3 and 5-CCCACTCAGACCAGTGGGCCGC
TTC-3. The PCR product was cloned into the Sma1 site in pGEX-quenched with 5 ml of 1 M triethylammonium bicarbonate (TEAB
buffer [pH 7.5]). Solvent was removed in vacuo at 	40
C by rotary KT1 (Pharmacia). All mutants of dok-1 were constructed by Quick-
Change protocol with 100 ng of wild-type dok-1 as a template. Theevaporation. The resulting slurry was purified on a DEAE (A-25)
Sephadex (Pharmacia) column with TEAB (pH 7.5) (0.1–0.5 M gradi- dok-1 Y397F mutant was used as a template for Y397/401F and
Y397/408F double mutants, whereas the dok-1 Y401F mutant wasent). The purified N6(benzyl) AMP shows a retention time of 7.5 min
on a strong anion exchange HPLC column (SAX, catalog # 83-E03- used for the Y401/408F double mutant.
Expression of wild-type and mutant GST-dok-1 was carried outETI, Varian) with a gradient of 5–750 mM ammonium phosphate (pH
3.9) for 10 min at a flow rate of 0.5 ml/min. in DH5 cells. A single colony was inoculated into 25 ml of LB
superbroth (Bio 101) liquid media with 100 g/ml ampicillin. TheIn the second step, a solution of N6(benzyl) AMP (44 mg, 0.1 mmol)
and carbonyl diimidazole (81 mg, 0.5 mmol) in DMF (5 ml) was stirred culture was grown at 37
C overnight. This culture was added to 250
ml LB superbroth (Bio 101). After 2 hr at 37
C (O.D.600  0.5), IPTGat room temperature for 20 hr, after which methanol (35 l) was
added. After 1 hr, a solution of tributyl ammonium phosphate was added to a final concentration of 1 mM. The culture was shaken
for 5–6 hr at 37
C and then was centrifuged at 2500  g for 15 min.(1 mmol) was added in DMF (1 ml). The reaction was stirred for an
additional 24 hr. After the reaction mixture was quenched with 2 ml The pellet was resuspended in 5 ml of 25 mM Tris (pH 8.0), 1 mM
EDTA, and 1 mM DTT buffer and lysed twice at 8000 psi in a Frenchof TEAB buffer (pH 7.5), solvent was removed in vacuo at 	40
C,
and the residue was purified as described above (retention time press at 4
C. The lysate was centrifuged again at 2500  g for 10
min. The supernatant was added to 1 ml of reconstituted glutathione9.7 min).
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beads (Sigma) and was gently shaken for 30 min on ice. The slurry other 2 hr at 4
C. The immune complexes were washed three times
(500 l each) in modified RIPA buffer without SDS and twice inwas added to a column (Fisher Scientific # 11-387-50), and the
beads were washed with 10 ml of 25 mM Tris (pH 8.0) and 10 mM kinase buffer (30 mM Tris [pH 7.5], 10 mM MgCl2, and 10 mM MnCl2).
Kinase reactions were initiated by the addition of 0.5 Ci of [-32P]EDTA buffer followed by 50 mM tris (pH 8.0) (5 ml). The glutathione
fusion protein was eluted with 4 ml of 10 mM free glutathione ATP alone or 1 Ci of [-32P] N6(benzyl) ATP in the presence of 10
M ATP and were incubated for 10–15 min (as indicated in the figure(Sigma), 50 mM Tris (pH 8.0), and 150 mM NaCl solution.
legends) at room temperature. After boiling for 5 min in sample
buffer, immune complex proteins were separated on 10% SDS-Cell Culture
PAGE gels, electrophoretically transferred, and exposed as de-NIH 3T3 cells were routinely grown in Dulbecco’s modified Eagle’s
scribed before.medium (DMEM) with 10% bovine calf serum (Hyclone-SH30072.03).
Wild-type and I338G v-Src (v-Src-as1) NIH 3T3 cells were routinely
grown in DMEM with 10% bovine calf serum and 2.5 g/ml puromy-
Kinase Assays with GST Fusion Proteinscin (Calbiochem).
The Dok-1 protein was expressed as a GST fusion protein in E.
coli to facilitate rapid mutagenesis and protein purification. TheseTransfection and Retroviral Infection
mutant proteins were phosphorylated with the same v-Src immuneBoth v-Src and v-Src-as1 pBabe puro plasmids were transiently
complex, and GST-fused Dok-1 was gel purified based on its largertransfected into Bosc 23 cells by the calcium phosphate transfection
molecular weight as compared to that of endogenous Dok-1. Themethod [62]. Culture medium containing the retroviruses was har-
recombinant GST-Dok-1 showed a phosphotryptic pattern of phos-vested from 72 hr to 5 days after transfection. Viral supernatants
phorylation identical to that of endogenous Dok-1.were stored at –80
C. Negative control retroviruses lacking v-Src
Purified wild-type and mutant GST-Dok-1 proteins were addedwere prepared by using pBabe puro or hygro vectors alone. 5 
to v-Src immune complexes in the presence of [-32P] ATP, and the105 NIH 3T3 cells were seeded on a 10 cm culture dish and were
kinase assay was carried out for 15 min at room temperature. Theallowed to attach to the plate for several hours. Infection was carried
reaction mixture was centrifuged (13,000 rpm), and the supernatantsout by adding the retrovirus supernatant (3 ml) in the presence of
were boiled in the sample buffer for 5 min. Proteins were resolvedpolybrene (4 g/ml). After 3 hr the viral supernatant was removed
on 10% SDS-PAGE, electrophoretically transferred to nitrocelluloseand replaced with fresh media (10% bovine calf serum/DMEM). After
membrane, and visualized as described above.48 hr the infected cells were selected in the presence of 2.5 g/ml
of puromycin. After another 24 hr, more than 95% of the cells were
viable by trypan blue staining. The expression of wild-type and
Kinase Assays with Recombinant Cofilin
v-Src-as1 in NIH 3T3 cells was confirmed by immunoprecipitation
Cofilin (Sigma) was added (2 g) to v-Src and v-Src-as1 immune
(GD11) and immunoblotting (EC10). Both wild-type and v-Src-as1
complexes in the presence of [-32P] ATP or [-32P] N6(benzyl) ATP,
proteins were present in equal amounts (data not shown). Accord-
and the kinase assay was carried out for 20 min at room temperature.
ingly, for Dok-1 coexpression in c-Src (T338I, Y527F) NIH 3T3 cells
The reaction mixture were boiled in the sample buffer for 5 min.
or in NIH3T3 cells, viral supernatants either of the wild-type or of
Proteins were resolved on 10% SDS-PAGE, electrophoretically
Dok-1 mutants were added to v-Src (hygro) and NIH 3T3 cells,
transferred to nitrocellulose membrane, and visualized as described
respectively, and were selected in the presence of 2.5 g/ml of
above.
puromycin.
Kinase Assays and 2D Gel Electrophoresis of v-Src Immunoblotting
and v-Src-as1 NIH 3T3 Cells PVDF membranes were blocked for varying amounts of time (2 hr
Cells were lysed at 4
C in modified RIPA buffer (1% NP 40, 50 mM to overnight) in 5% BSA in TBS-Tween (50 mM Tris [pH 8.00], 150
Tris [pH 7.5], 150 mM NaCl, 0.25% sodium deoxycholate, 2 mM mM NaCl, 0.1% Tween 20) and then probed with antibodies in 1%
EGTA, 1 mM phenylmethylsulfonyl fluoride [PMSF], 10 g/ml leu- BSA in PBS. Horseradish peroxidase (HRP)-conjugated anti-mouse
peptin, and 10 g/mL aprotinin) and cleared by centrifugation at antibody (VWR # 55550) was used for the detection of monoclonal
13,000 rpm for 15 min at 4
C. Cleared lysates were mixed with 10 antibodies, and HRP-conjugated goat anti-rabbit antibody (VWR #
MgCl2, 10 mM MnCl2, 1 mM sodium orthovanadate, 100 M ATP, RL 611-103-122) was used for the detection of p62 Dok. Enhanced
5 Ci of [-32P] ATP (6000 Ci/mmol) (Figure 1, lanes 1 and 2) or chemiluminescence (Pierce) was used for antibody detection as
[-32P] N6 (benzyl) ATP (8500 Ci/mmol) (lanes 3 and 4) and were described in the manufacturer’s instructions.
incubated for 45 min at room temperature. Cell lysates were boiled
for 5 min in sample buffer (62.5 mM Tris (pH 6.8), 2.5% SDS, 10%
glycerol, 2.5 mg/ml DTT, 2.5% -mercaptoethanol) and separated Phosphotryptic Peptide Mapping
on 10% SDS-PAGE gels. Separated proteins were electrophoreti- Immunoprecipitations and in vitro kinase assays with GST-Dok pro-
cally transferred to immobilon polyvinylidene membranes (Millipore, teins were performed as described above. 32P-labeled Dok-1 bands
Bedford, Massachusetts) with a semidry apparatus (Owl Scientific) were excised from the nitrocellulose membrane, and phosphotryptic
for 1 hr at 10 V. For autoradiography, the membranes were exposed peptide mapping procedures were carried out according to the
to Kodak Biomax MS film (Kodak) with a Biomax MS intensifying methods of Boyle et al. [45]. The nitrocellulose membrane carrying
screen at 70
C. the protein was soaked in 0.5% PVP-360 in 100 mM acetic acid at
2D gel electrophoresis of radiolabeled samples was carried out by 37
C for 30 min, after which it was washed extensively with 0.05 M
Kendrick Labs (Madison, Wisconsin) with 2% pH 3.5–10 ampholines NH4HCO3. Ten micrograms of TPCK-treated trypsin (Worthington,
(Pharmacia) for 9600 volt hr. One mg of an IEF internal standard, Freehold, New Jersey) in 0.1 mM HCl (1 mg/ml) was added to the
tropomyosin, was added to each sample. Ten percent SDS slab membrane soaked in 200 l of NH4HCO3 and was incubated at 37
C
electrophoresis was carried out for about 4 hr at 12.5 mA/gel. The for 2 hr. At the end of the digestion, 300 l of water was added,
gels were stained with Coomassie blue, dried, and exposed to Ko- and the supernatant was lyophilized. Chilled performic acid (100 l)
dak X-OMAT AR film. was then added, and the oxidation was carried out at 4
C for 1
hr, followed by the addition of 400 l of water and lyophilization.
Phosphotryptic peptides were resolved on cellulose TLC (thin-layerImmunoprecipitation and Kinase Assays of v-Src
and v-Src-as1 NIH 3T3 Cells chromatography) plates by electrophoresis in pH 1.9 buffer (1000
V for 70 min) in the first dimension, followed by ascending chroma-Unless otherwise specified, cells were lysed at 4
C in modified RIPA
buffer with 0.1% SDS and 2 mM sodium orthovanadate. After centrif- tography in phosphochromo buffer (25% pyridine, 7.5% glacial ace-
tic acid, 37.5% 1-butanol in water) in the second dimension. Labeledugation, the cleared lysate was incubated with 1–5 g of the desired
antibody at 4
C for 2 hr with gentle rotation, followed by incubation peptides were detected by autoradiography by exposing the plate
to Kodak Biomax MS film (Kodak) with a Biomax MS intensifyingwith 50 l of 50% protein A Sepharose slurry (Pharmacia) precoated




Soft-Agar Colony Formation Assay Identification of novel MAP kinase pathway signaling targets
by functional proteomics and mass spectrometry. Mol. Cell 6,Wild-type and I338G v-Src-expressing NIH 3T3 cells and pBabe
vector-infected NIH 3T3 cells were plated in DMEM (103, 104, and 1343–1354.
10. Zhou, S., and Cantley, L.C. (1995). Recognition and specificity105 cells per dish, each in triplicate), 0.3% agar, and 10% bovine
calf serum in 35  10 mm dishes. Transformed colonies were in protein tyrosine kinase-mediated signaling. Trends Biochem.
Sci. 20, 470–475.counted after 3 weeks.
11. Pawson, T., and Nash, P. (2000). Protein-protein interactions
define specificity in signal transduction. Genes Dev. 14, 1027–Mass Spectral Analysis
1047.Gel spots were digested by adding 0.05 g modified trypsin in the
12. Cohen, P. (2000). The regulation of protein function by multisiteminimum amount of 0.025 M Tris (pH 8.5) and leaving the gel over-
phosphorylation—a 25 year update. Trends Biochem. Sci. 25,night at 32
C. Peptides were extracted with 2 50l of 50% acetoni-
596–601.trile/2% TFA, and the combined extracts were dried and resus-
13. Ellis, C., Moran, M., McCormick, F., and Pawson, T. (1990).pended in matrix solution prepared by making a 10 mg/ml solution
Phosphorylation of GAP and GAP-associated proteins by trans-of 4-hydroxy--cyanocinnamic acid in 50% acetonitrile/0.1% TFA
forming and mitogenic tyrosine kinases. Nature 343, 377–381.and adding two internal standards, angiotensin and bovine insulin,
14. Kaplan, D.R., Morrison, D.K., Wong, G., McCormick, F., andto the matrix solution. MALDI mass spectrometric analysis was per-
Williams, L.T. (1990). PDGF beta-receptor stimulates tyrosineformed on the digest by using a PerSeptive Voyager DE-RP mass
phosphorylation of GAP and association of GAP with a signalingspectrometer in the linear mode. These peptides were analyzed by
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